De-escalation Therapy in Stage I ER-Positive Breast Cancer: A Non-Inferiority Trial
NCT07153757
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
2934
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Interventions
DRUG:
Endocrine Therapy of Physician's Choice
Sponsor
Fudan University